Since
our founding, YalePharma
has been willing to
place our own resources,
talent and expertise
on the line to develop
value-added products
that benefit consumers
and stockholders alike.
Through internal research
and development, we
make good drugs better,
finding ways to deliver
them with greater safety,
stability and/or effectiveness.
Our technological achievements
are possible because
of our skillful employee
teams, who lend vision
and enthusiasm to our
continual quest for
quality.
Yale
Pharmaceutical Research
Institute, US
Beijing
YalePharma Research
Institute, China
Rotterdam
YalePharma Research
Institute, Netherlands
Vancuver
YalePharma Research
Institute, Canada
Piplines
The
table below shows a
selection of key drugs
in late stages of development
or pending registration
in the U.S. by one of
our operating companies.
This list is not meant
to be exhaustive, and
the products shown here
are intended for use
by patients in the U.S.
only. Some of these
products may already
be marketed in countries
outside the U.S., or
may be under consideration
for development in other
countries.
|
Disease
Area
|
Pre-
Clinical
|
IND
|
I
|
I/II
|
II
|
II/III
|
III
|
BLA
/ NDA / ANDA
|
Market
|
Total
Diseases
|
|
BLOOD
DISORDERS
|
- |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3
|
3 |
|
BONE,
MUSCLE AND JOINT
|
3
|
-
|
-
|
-
|
1
|
-
|
2
|
2
|
3
|
11
|
|
BRAIN
AND NERVE DISORDERS
|
6
|
-
|
1
|
-
|
6
|
-
|
3
|
4
|
13
|
33
|
|
BREAST
DISORDERS
|
1
|
-
|
-
|
-
|
1
|
-
|
-
|
1
|
2
|
5
|
|
CANCER
TREATMENT
|
5
|
-
|
2 |
1
|
6
|
-
|
1
|
-
|
1
|
16
|
|
CHILDREN'S
HEALTH
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3
|
3
|
|
DIAGNOSTIC
PROCEDURE
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
1
|
|
DIGESTIVE
DISORDERS
|
3
|
-
|
1
|
1
|
4
|
-
|
1
|
-
|
5
|
15
|
|
EAR,
NOSE AND THROAT
DISORDERS
|
-
|
-
|
-
|
-
|
2
|
-
|
-
|
-
|
2
|
4
|
|
EYE
DISORDERS
|
3 |
-
|
-
|
-
|
1
|
-
|
1
|
-
|
4
|
9
|
|
FEMALE
REPRODUCTIVE SYSTEM
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
4
|
5 |
|
GENETIC
DISORDERS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
|
HEART
& BLOOD VESSEL
DISORDERS
|
5
|
-
|
-
|
1
|
5
|
-
|
1
|
1
|
16
|
29
|
|
HORMONAL
DISORDERS
|
2 |
-
|
1
|
-
|
2
|
-
|
-
|
3
|
9
|
17
|
|
IMMUNE
DISORDERS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
10
|
10
|
|
INFECTIONS
& INFECTIOUS
DISEASES
|
3
|
-
|
1
|
-
|
-
|
1
|
1
|
2
|
9
|
17
|
|
INFLAMMATORY
DISORDERS
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
1
|
4
|
7
|
|
KIDNEY
AND URINARY TRACT
|
-
|
-
|
1
|
-
|
1
|
-
|
1
|
-
|
2
|
5
|
|
LIVER
AND GALLBLADDER
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
1
|
|
LUNG
AND AIRWAY DISORDERS
|
1 |
-
|
-
|
1
|
3
|
-
|
2
|
2
|
8
|
17
|
|
MENTAL
HEALTH
|
6 |
-
|
2
|
-
|
1
|
-
|
2
|
4
|
9
|
24
|
|
NUTRITION
AND METABOLISM
|
6
|
1
|
1
|
-
|
-
|
-
|
1
|
-
|
6
|
15
|
|
PENIS,
PROSTATE, &
TESTES DISORDERS
|
1
|
-
|
-
|
2
|
2
|
1
|
-
|
2
|
1
|
9
|
|
REPRODUCTIVE
HEALTH
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
5
|
5
|
|
SEXUALLY
TRANSMITTED DISEASES
|
-
|
-
|
-
|
2
|
1
|
-
|
-
|
-
|
1
|
4
|
|
SKIN
DISORDERS
|
1
|
-
|
-
|
-
|
-
|
2
|
-
|
-
|
4
|
7
|
|
SURGERY
|
-
|
-
|
-
|
-
|
-
|
1
|
4
|
-
|
1
|
6
|
|
Total
Disease Targets:
|
46
|
1 |
10
|
8
|
37
|
5
|
22
|
23
|
127
|
279 |
|
Total
Trials:
|
46 |
1
|
10
|
8
|
37
|
5
|
22
|
23
|
127
|
152
|
